ACADIA Pharmaceuticals Inc (ACAD)

45.75 -1.15  -2.45% NASDAQ Jun 4, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
07/31/2020 16:30 EDT Misc ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2020
07/31/2020 Earnings ACADIA Pharmaceuticals Inc Second Quarter Earnings in 2020 Release
06/23/2020 08:00 PDT Misc ACADIA Pharmaceuticals Inc Annual General Meeting for 2019
05/07/2020 16:30 EDT Misc ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020
05/07/2020 Earnings ACADIA Pharmaceuticals Inc First Quarter Earnings Result for 2020
02/27/2020 Misc ACADIA Pharmaceuticals Inc Annual Report for 2019
02/26/2020 17:00 EST Misc ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
02/26/2020 Earnings ACADIA Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
10/30/2019 16:30 EDT Misc ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019
10/30/2019 Earnings ACADIA Pharmaceuticals Inc Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.acadia-pharm.com
  • Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Jul. 31, 2020
  • Last Earnings Release: May. 07, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Top Fund Holders

Symbol Name Weighting
ASYMX Alger Weatherbie Specialized Growth Y 3.20%
PTH Invesco DWA Healthcare Momentum ETF 2.36%
XBI SPDR® S&P Biotech ETF 1.71%
CEARX Columbia Acorn Adv 1.43%
FBIOX Fidelity® Select Biotechnology 1.36%
FGKFX Fidelity® Growth Company K6 0.91%
FCGSX Fidelity® Series Growth Company 0.91%
FGCKX Fidelity® Growth Company K 0.89%
HQH Tekla Healthcare Investors 0.84%
IBB iShares Nasdaq Biotechnology ETF 0.80%
IWO iShares Russell 2000 Growth ETF 0.51%
IWM iShares Russell 2000 ETF 0.29%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.